Doctor profile · Federal record
Dr. Mark Fradin, M.D.
Dermatology Physician (CMS: Dermatology) · Chapel Hill, NC
- NPI 1306809157
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 40 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
891 Willow Dr, Suite 1
Chapel Hill, NC 275147077
(919) 942-3106
fax (919) 967-1674
Credentials & registration
- NPI registered
- April 2006 — 20 yrs on file
- Profile last updated
- March 2, 2011
- Year of graduation
- 1986 — 40 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- North Carolina #39263
- Medicaid
- NC #8933655
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1306809157. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,545
Distinct HCPCS
10
Medicare allowed
$234,977
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,850 | 300 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 802 | 597 | $85 | |
17000 |
Destruction of precancer skin growth, 1 growth | 478 | 374 | $49 | |
11102 |
Biopsy of related skin growth, first growth | 462 | 350 | $88 | |
11103 |
Biopsy of related skin growth, each additional growth | 196 | 117 | $47 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 196 | 167 | $53 | |
17110 |
Destruction of skin growth, 1-14 growths | 152 | 140 | $104 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 151 | 137 | $121 | |
17262 |
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 90 | 67 | $154 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 77 | 63 | $157 |
In context: peer comparison
Among 15 peers in Chapel Hill Dermatology Physician, average services per provider: 157. This provider delivers 29× the peer median.Open Payments
Industry payments received
All-time total
$1,420
Transactions
51
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Hill Dermaceuticals, INC. | 1 | $297.79 | |
| E.R. Squibb & Sons, L.L.C. | 16 | $269.37 | |
| Regeneron Healthcare Solutions, INC. | 11 | $245.30 | |
| Sun Pharmaceutical Industries INC. | 4 | $142.95 | |
| Novartis Pharmaceuticals Corporation | 5 | $136.98 | |
| Genzyme Corporation | 3 | $99.98 | |
| Abbvie INC. | 4 | $90.24 | |
| Janssen Biotech, INC. | 3 | $67.51 | |
| Galderma Laboratories, L.P. | 2 | $31.77 | |
| Amgen INC. | 1 | $24.11 | |
| Arcutis Biotherapeutics, INC. | 1 | $13.77 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
581
Patients
357
Total drug cost
$327,606
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Fluocinonide | Generic | 74 | 63 | $2,963 |
| Doxycycline Hyclate | Generic | 64 | 36 | $1,680 |
| Minoxidil | Generic | 61 | 25 | $580 |
| Triamcinolone Acetonide | Generic | 58 | 45 | $459 |
| Ketoconazole | Generic | 46 | 42 | $1,358 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 44 | 29 | $984 |
| Finasteride | Generic | 40 | 17 | $365 |
| Clobetasol Propionate | Generic | 34 | 26 | $1,522 |
| Mupirocin | Generic | 31 | 28 | $308 |
| Minocycline Hcl | Generic | 29 | 21 | $857 |
Frequently asked questions
What is Dr. Mark Fradin's medical specialty?
Dr. Mark Fradin practices Dermatology Physician in Chapel Hill, NC.
Where does Dr. Mark Fradin practice?
Dr. Mark Fradin practices at 891 Willow Dr, Chapel Hill, NC 275147077. Office phone: 9199423106.
What is Dr. Mark Fradin's NPI?
Dr. Mark Fradin's National Provider Identifier (NPI) is 1306809157, issued by NPPES.
Does Dr. Mark Fradin accept Medicare assignment?
Yes. Dr. Mark Fradin accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Fradin commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.